Corning Clinical Laboratories and NeoPath Inc. announce contract for AutoPap 300 QC System.REDMOND, Wash.--(BUSINESS WIRE)--Oct. 26, 1995--Corning Clinical Laboratories (CCL 1. CCL - Coral Common LISP. 2. CCL - Computer Control Language. English-like query language based on COLINGO, for IBM 1401 and IBM 1410. ) today announced an agreement to use NeoPath's(R) breakthrough technology to improve the accuracy of Pap smear Pap smear or Papanicolaou smear Sample of cells from the vagina and cervix of the uterus for laboratory staining and examination to detect genital herpes and early-stage cancer, especially of the cervix. Developed by the Greek-born U.S. screening for the early detection of cervical cancer Cervical Cancer Definition Cervical cancer is a disease in which the cells of the cervix become abnormal and start to grow uncontrollably, forming tumors. . The technology, NeoPath's AutoPap(R) 300 QC System, will be part of quality control procedures for the rescreening of Pap smears. CCL, one of the first laboratories in the world scheduled to implement the technology, intends to install the first group of instruments at its Wood Dale, Ill., (Chicago) facility. CCL expects to begin offering the new technology to its Chicago-area clients as early as January 1996. The AutoPap 300 QC System is a quality control device that rescreens Pap smear slides initially classified as normal by a trained screener or cytotechnologist cy·to·tech·nol·o·gist n. A technician trained in medical examination and identification of cellular abnormalities. cytotechnologist a medical laboratory technologist specializing in cytology. . Pap smears, a vital component of women's health Women's Health Definition Women's health is the effect of gender on disease and health that encompasses a broad range of biological and psychosocial issues. care, detect cancer and pre-cancerous conditions of the uterine cervix. Federal quality control guidelines now rely upon random rescreening of a portion of cytotechnologist-screened normal slides. In clinical trials, the AutoPap 300 QC System was shown to enhance this current method of quality control by allowing the laboratory to rescreen normal Pap smears in a focused vs. a random approach. On Sept. 29, 1995, the U.S. Food and Drug Administration granted NeoPath PMA PMA (papillary-marginal-attached), n a system of epidemiologic scoring of periodontal disease devised by Schour and Massler in which the symbols denote the areas involved in gingival inflammation. PMA Progressive muscular atrophy approval to market the AutoPap 300 QC System based on extensive clinical trials that showed the device reduces the false negative rate of Pap smear testing in U.S. clinical laboratories. "We are very pleased to be among the first laboratories in the world to offer this exciting new technology," said Kim Lamon, M.D., CCL's chief medical officer and senior vice president for science and technology. "It may well represent the first major improvement in cervical cancer screening since the Pap smear became available some 50 years ago." Corning Clinical Laboratories operates 25 testing facilities covering 44 states for managed care organizations, physicians and hospitals. CCL is a wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. of Corning Inc., a Fortune 500 company, based in Corning, N.Y. The AutoPap 300 QC System, developed by NeoPath Inc., is a medical device that integrates proprietary high-speed image processing computers, video imaging technology and sophisticated image interpretation software to capture and analyze thousands of microscopic images from a Pap smear slide. NeoPath Inc. developed the AutoPap 300 QC System in pursuit of its goal to help eradicate cervical cancer worldwide. The company's core expertise is in the research, development, and commercialization of technologies to automate the interpretation of medical images. The company, with headquarters in Redmond, has approximately 110 employees. CONTACT: Corning Inc. Kim Lamon, M.D., Ph.D., Chief Medical Officer, 607/974-8206 or NeoPath Inc. John Stachowiak, VP, Finance and Administration, 206/869-7284 Volker Kettering, VP, Sales, 206/869-7284 or Fi.Comm Michael Newman, Investor Relations Investor relations The process by which the corporation communicates with its investors. , 206/467-6732 or EvansGroup Public Relations public relations, activities and policies used to create public interest in a person, idea, product, institution, or business establishment. By its nature, public relations is devoted to serving particular interests by presenting them to the public in the most Steve Bryant, Media Relations, 206/270-4664 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion